Seeking Alpha

Chet2006

Chet2006
Send Message
View as an RSS Feed
Latest comments  |  Highest rated
  • Stocks Worth Buying Before Earnings: Week 6 [View article]
    I've stuck with SPPI, and I've seen 100+% gains on it so far. I agree that this year will be big for its growth, but I'm wondering what your reasoning is for the second-half pop. Is this prediction based on Apaziquone and Belinostat NDA filings and of course increasing revenue from Zevalin and probably Fusilev too? Or are there more catalysts coming?

    Also, how do you think SPPI would be affected if the FDA pushes ways to address the leucovorin shortage?
    Feb 25, 2012. 03:18 AM | Likes Like |Link to Comment
COMMENTS STATS
1 Comment
0 Likes